CHANDRA SEKHAR PASULA; DR. SAVITHIRI SHIVAKUMAR; YASODHA LAKSHMI T; RAJA RATNA REDDY Y; DR. S. RAMAMOORTHY. Effect of quercetin and prima-1MET (P53 activator) combination therapy on P53 mutant type human colon cancer cells (COLO-320). International Journal of Pharma and Bio Sciences, [S. l.], v. 10, n. 1, p. 61–67, 2019. DOI: 10.22376/ijpbs.2019.10.1.p61-67. Disponível em: https://ijpbs.net/index.php/journal/article/view/6605. Acesso em: 23 jul. 2026.